2019, Number 3
PDF size: 327.84 Kb.
ABSTRACTIntroduction: Intracranial aneurysms are cerebral vascular anomalies with an approximate global prevalence of 2 to 3% and are the main cause of non-traumatic subarachnoid hemorrhage. Diagnosis and preventive treatment of this entity can considerably reduce morbidity and mortality. With the advent of new devices for cerebral endovascular therapy such as flow diverters, the patient now has the option of choosing a less invasive procedure, which does not require conventional surgery. This represents a significant reduction in the number of days of in hospital stay and recovery. The procedure has showed a high degree of security. The endovascular treatment for intracranial aneurysms has evolved substantially in the last two decades, and has become the treatment of choice.
Case report: Case 1: A 62-year-old male was admitted in the hospital after a moderate cranioencephalic trauma with transient loss of conscious and a holocranial headache. A cerebral angiography was performed to rule out subarachnoid hemorrhage. The angiography showed an intracranial aneurysm. It was localized in left internal carotid-posterior communicating artery. The measures were of 4mm X 3mm with a 3mm neck. The treatment was performed with a pipeline flow-diverting device, as well as an angiographic control 3 months after the treatment with a satisfactory evolution.
Case 2: A 59-year-old female patient with facial hemiparesis and ipsilateral arm, that showed a gradual increase in intensity and duration. A magnetic resonance study protocol was initiated and an intracranial aneurysm was observed in the communicating segment of the right internal carotid artery. The diameter of the aneurysmal sac was of 15 mm and also, a contralateral of 8 mm. Placement of a flow-diverting device was programmed.
Conclusion: The use of flow-diverting devices is an excellent alternative for the treatment of incidental intracranial aneurysms, with important cost-effectiveness advantages, surgical time, hospital stay and recovery reduction. In addition to having a recovery percentage of 95% in 5 years.
Van Lieshout Jasper H, Dibue-Adjei Maxine et al. An Introduction to the pathophysiology of aneurysmal subarachnoid hemorrhage. Neurosurgery Rev. 2018;41(4)917- 30. DOI: 10.1007/s10143-017-0827-y
Zhinyuan Zheng V, Know Chu Wong G. Neuroinflammation Reponses after Subarachnoid Hemorrhage: A review. Journal of Clinical Neuroscience. 2017;42:7-11. http://dx.doi.org/10.1016/j.jocn.2017.02.001
D’Souza Stanlies et al. Aneurysmal Subarachnoid Hemorrhage. Journal Neurosurgery anesthesiology. July 2015; 27(3):222-40.
Briganti F, Leone G, et al. Endovascular Treatment of Cerebral Aneurysms Using Flow Diverter devices: A Systematic Review. Neuroradiol J. 2015 Aug;28(4):365- 75. doi: 10.1177/1971400915602803
Jevsek M, Mounayer C, Seruga T. Endovascular treatment of unrupted aneurysms of cavernous and ophthalmic segment of internal carotid artery with flow diverter device pipeline. Radiology and Oncology. 2016;50(4):378-84.
Brown RD Jr, Broderick JP. Unruptured intracranial aneurysms: epidemiology, natural history, management options, and familial screening. Lancet Neurol. 2014 Apr;13(4):393-404. doi: 10.1016/S1474-4422(14)70015-8.
Saatci I, Yavuz K, et al. Treatment of Intracranial Aneurysms Using the Pipeline Flow Diverter Embolization Device: A Single–Center Experience with Long Term Follow up Results. AJNR. 2012;33:1436-46. doi:http:// dx.doi.org/10.3174/ajnr. A3246
Tromp G, Weinsheimer S, et al. Molecular Basis and Genetic Predisposition to Intracranial Aneurysms. Annals of medicine. 2014;46:597-606. DOI: 10.3109/07853890.2014.949299
Jorman H. Tejada, Miguel F. Sandoval, José D. Charry, Andrés Fonnegra. Uso dispositivo diversor de flujo pipeline ® para tratamiento endovascular de aneurisma intracraneal distal gigante. Rev Argent Neuroc. 2015;29(4):164-7.
Lylyk P, Miranda C, Ceratto R, Ferrario A, Scrivano E, Luna HR, et al. Curative Endovascular Reconstruction of Cerebral Aneurysms With The Pipeline Embolization Device: The Buenos Aires Experience. Neurosurgery. 2009;64(4):632- 42. DOI: 10.1227/01.NEU.0000339109.98070.65 www. neurosurgery- online.com
Liang F, Zhang Y, Guo F, Zhang Y, Yan P, Liang S, et al. Use of Pipeline Embolization Device for Posterior Circulation Aneurysms: Single-Center Experiences with Comparison with Anterior Circulation Aneurysms. World Neurosurg. 2018 Apr;112:e683-e690. doi: 10.1016/j. wneu.2018.01.129
Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, Holman R; International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet. 2002 Oct 26;360(9342):1267-74.
Texakalidis P, Bekelis K. Flow Diversion with the Pipeline Embolization Device for Patients with Intracranial Aneurysms and Antiplatelet Therapy: A Systematic Literature Review. Clinical neurology and neurosurgery. 2017;161:78- 87. DOI: http://dx.doi.org/10.1016/j.clineuro.2017.08.003
Yiu-Wah Fan, Wai-Man Lui. Management of Unruptured Intracranial Cerebral Aneurysms. Hong Kong Medical Diary. 2011 February;16(2):6-8.